Precision Medicine will need to get out of the pharma silo that is based on symptoms

Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!

Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.

After low-cost airlines (Ryanair, Easyjet ...) comes "low-cost" participatory medicine. Some of my readers have recently christened this long-lasting, clumsy attempt at e-writing of mine "THE LOW-COSTE INNOVATION BLOG". I am an
early adopter of scientific MOOCs. My name's Catherine Coste. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs?

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC ( to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (

Genomics Pioneer: We Are a Software Driven Species. Super-organs: building body parts better than nature.

Genomics Pioneer: We Are a Software Driven Species, like all biology on the planet. If you change the software, you change the species.
This video is a bit funny on bunnies, but just check it out!
J. Craig Venter, the first scientist to sequence the human genome, describes the chemical and genetic basis of life as software. "Most people view themselves as static entities, not billions of reactions going on from constantly reading that software," he says.

"FANCY a liver that works a little harder? Synthetic DNA circuits inserted into human stem cells could soon allow us to build new organs with unprecedented precision and speed. The circuits can be designed on a computer and assembled from ready-made parts ordered online. The technique could prove an efficient way of making organs for transplant without the worry of rejection, and raises the tantalising possibility that it might one day be possible to upgrade the organs we were born with. Human cells have already been used to create a tiny liver and a set of neurons.

'At the moment, the aim is to normalise cells, but in future, enhancement has to be on the menu,' says Chris Mason, a professor of regenerative medicine at University College London, who wasn't involved in the work.
'Everything we have in our bodies is hardwired,' says synthetic biologist Patrick Guye at the Massachusetts Institute of Technology, part of the team pioneering the new approach. Apart from egg and sperm cells, all our cells contain exactly the same genetic instructions. They develop into different kinds of cell because 'epigenetic' switches turn some genes on and others off. By hijacking this mechanism, we can rewind adult cells to an embryonic-like state and make them develop into different tissues.
To turn these induced pluripotent stem (iPS) cells into a specific tissue type, they are typically placed in a soup of DNA and signalling molecules. These enter the cells and flick certain epigenetic switches. What gets turned on or off depends on the ingredients in the soup. 'The problem is that there are tens of thousands of these switches that all need to be set in the right way,' says Mason. Another hurdle is that all cells in the soup are influenced in the same way and grow into the same tissue type. But a piece of liver tissue, say, is not the same as a functioning liver. The issue is even more apparent with complex organs such as hearts, says Guye.
What would be more helpful is an instruction manual that each individual stem cell can follow during its development. And this is exactly what Guye's team has provided. They started by looking at what happens in neurons and liver cells during natural embryonic development – which genes are switched on and when. They then designed and built artificial DNA control circuits to reproduce this switching in iPS cells. The circuits are slotted together using a combination of standard DNA parts – such as sequences that code for different proteins – available from online repositories and newly synthesised genetic material. These circuits were then chemically inserted into thousands of iPS cells (Nucleic Acids Research,"

Control from inside


"'You assemble it into one large logic circuit and put it into the cell,' Guye says. 'It's interfacing with the natural system. We're not replacing anything, we're putting a control layer on top.'

Once in the cell, the circuitry kicks into action. 'The idea is that the circuit is pretty much autonomous,' says Guye. It can measure activity – such as levels of gene expression in the cell – and react to it. When the circuit detects that an iPS cell has turned into a precursor cell, for example, it can initiate the next stage of development.
As yet unpublished results suggest that the technique is faster and more reliable than existing methods of creating tissues from iPS cells (see Programming a new liver). In one study, his team turned iPS cells into neurons in just four days with almost 100 per cent success. 'If true, it's incredibly rapid,' says Mason. 'Normally it takes weeks.'
Another advantage of Guye's approach is that it only requires cells from one person. 'You get an organ that really corresponds to an individual,' he says.
But before the technique can be used to grow organs for transplant, Guye's team needs to find a way to get rid of the artificial DNA once it has done its job. It currently lasts inside the cells for a few weeks, and is passed on when they replicate – it 'becomes physically part of the genome'. Although the artificial DNA is unlikely to cause any harm, people will have legitimate concerns about long-term implications, says Guye. One solution would be to build circuits out of messenger RNA, which would survive long enough to push the cells in one developmental direction and then degrade after a few days.
'We are overriding the natural programming with our gene circuit,' says Guye, who presented the work at the International Meeting on Synthetic Biology at Imperial College London earlier this month. 'The cells already have the knowledge. We are just helping them get on their way.' For many, however, the ideal is to create tissues and organs with added extras such as resistance to parasites (see 'Designer organs to order').
'This is what we are going to do,' says Mason, although he admits we're not there yet and the regulators certainly aren't. Takanori Takebe at Yokohama City University in Japan agrees. 'I think it is theoretically possible to improve the functions of generated organs,' says Takebe, whose group recently got three cell types to self-assemble into a tiny liver similar to the one Guye has made. Ethical discussions will be needed though, he adds.
'At the moment, it exceeds our knowledge,' says Guye. 'We would need to re-engineer much more than our gene circuit.' But in the long term, he thinks the limitations will be conceptual rather than technical. 'What type of new organ or function would one wish for?'
'At the moment, the aim is to normalise cells, but in future, enhancement has to be on the menu,' says Chris Mason, a professor of regenerative medicine at University College London, who wasn't involved in the work.

Oxford Journal Nucleic Acids Research - Rapid, modular and reliable construction of complex mammalian gene circuits
ABSTRACT Rapid, modular and reliable construction of complex mammalian gene circuits

We developed a framework for quick and reliable construction of complex gene circuits for genetically engineering mammalian cells. Our hierarchical framework is based on a novel nucleotide addressing system for defining the position of each part in an overall circuit. With this framework, we demonstrate construction of synthetic gene circuits of up to 64 kb in size comprising 11 transcription units and 33 basic parts. We show robust gene expression control of multiple transcription units by small molecule inducers in human cells with transient transfection and stable chromosomal integration of these circuits. This framework enables development of complex gene circuits for engineering mammalian cells with unprecedented speed, reliability and scalability and should have broad applicability in a variety of areas including mammalian cell fermentation, cell fate reprogramming and cell-based assays.

Organs enhanced with sensor or that release drugs on demand

In theory, he says, we can imagine creating a human organ for detecting magnetic fields – birds have such things, for example. But augmenting organs, rather than making entirely new ones, is within closer reach. Synthetic biology provides a rapidly increasing number of biological sensors that react to different stimuli. These could be inserted into tissues so that gene expression could be controlled by light alone, say, which may allow less invasive treatments.

People with brain disorders like Parkinson's, caused by the loss of nerve cells that produce dopamine, could benefit from neurons that release an extra hit. Growing 1000 more-potent brain cells instead of 100,000 normal cells would make cell therapies more affordable and quick to implement, says Chris Mason of University College London.

Other ideas suggested by researchers contacted by New Scientist include organs that can release drugs on demand, that are resistant to parasites or that break down toxins we can't deal with."

"Super-organs: building body parts better than nature", 24 July 2013 by Douglas Heaven, Magazine issue 2927.

"Super-organs: building body parts better than nature. "

Aucun commentaire: